Biermann J, Melms JC, Amin ADipak, Wang Y, Caprio LA, Karz A, Tagore S, Barrera I, Ibarra-Arellano MA, Andreatta M et al..  2022.  Dissecting the treatment-naive ecosystem of human melanoma brain metastasis.. Cell. 185(14):2591-2608.e30.

Mahase SS, Navrazhina K, Schwartz TH, Parashar B, A Wernicke G.  2019.  Intraoperative brachytherapy for resected brain metastases.. Brachytherapy. 18(3):258-270.

Lockney NA, Wang DG, Pei X, Goldman DA, Zhang Z, Lin A, Chan TA, Yamada Y, Beal K, T Yang J.  2018.  Phosphatidylinositol-3-Kinase Mutations Are Associated With Increased Local Failure in Brain Metastases Treated With Radiation.. Int J Radiat Oncol Biol Phys. 101(4):833-844.

Patel T, Bander ED, Venn RA, Powell T, Cederquist GYoung-Min, Schaefer PM, Puchi LA, Akhmerov A, Ogilvie S, Reiner AS et al..  2018.  The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas.. Neurosurgery. 82(6):808-814.

Lockney NA, Wang DG, Gutin PH, Brennan C, Tabar V, Ballangrud A, Pei X, Chan TA, Yamada Y, T Yang J et al..  2017.  Clinical outcomes of patients with limited brain metastases treated with hypofractionated (5×6Gy) conformal radiotherapy.. Radiother Oncol. 123(2):203-208.

Herting CJ, Chen Z, Pitter KL, Szulzewsky F, Kaffes I, Kaluzova M, Park JC, Cimino PJ, Brennan C, Wang B et al..  2017.  Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.. Glia. 65(12):1914-1926.

Du W, Seah I, Bougazzoul O, Choi GH, Meeth K, Bosenberg MW, Wakimoto H, Fisher D, Shah K.  2017.  Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.. Proc Natl Acad Sci U S A. 114(30):E6157-E6165.

Behling K, Maguire WF, Puebla JCarlos Ló, Sprinkle SR, Ruggiero A, O'Donoghue J, Gutin PH, Scheinberg DA, McDevitt MR.  2016.  Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.. J Nucl Med. 57(10):1576-1582.

Thomas AA, Fisher JL, Rahme GJ, Hampton TH, Baron U, Olek S, Schwachula T, C Rhodes H, Gui J, Tafe LJ et al..  2015.  Regulatory T cells are not a strong predictor of survival for patients with glioblastoma.. Neuro Oncol. 17(6):801-9.

McCrea HJ, Bander ED, Venn RA, Reiner AS, J Iorgulescu B, Puchi LA, Schaefer PM, Cederquist G, Greenfield JP.  2015.  Sex, Age, Anatomic Location, and Extent of Resection Influence Outcomes in Children With High-grade Glioma.. Neurosurgery. 77(3):443-52;discussion452-3.

Verma N, Nolan C, Hirano M, Young RJ.  2014.  Intramedullary spinal cord and leptomeningeal metastases from intracranial low-grade oligodendroglioma.. Clin Imaging. 38(4):505-507.

Bruna A, Darken RS, Rojo F, Ocaña A, Peñuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J et al..  2007.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.. Cancer Cell. 11(2):147-60.